Form 4: BeyondSpring Inc. Director, Brendan Delaney, Acquires Stock Options

Brendan Delaney, a Director at BeyondSpring Inc., reports the acquisition of stock options to purchase 21,822 ordinary shares.

Summary

• On April 21, 2025, Brendan Delaney, a Director of BeyondSpring Inc., acquired 21,822 stock options.
• These options, with an exercise price of $1.31, are exercisable for ordinary shares.
• The options were granted under the 2017 Omnibus Incentive Plan.
• The stock options will vest on April 21, 2026, contingent upon Delaney's continued service with BeyondSpring Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and generally viewed as a positive incentive for management.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders, incentivizing him to work towards the company's success.

Industry Context

This is a standard practice for incentivizing company directors and aligning their interests with shareholders.

Comparison to Industry Standards

• Stock option grants to directors are a common practice across the biotechnology industry to incentivize performance and align interests with shareholders.
• Comparable companies often use similar incentive plans with vesting schedules tied to continued service or performance milestones.
• The specific terms of the option grant, such as the exercise price and vesting schedule, are generally benchmarked against industry standards and company-specific factors.

Stakeholder Impact

• The granting of stock options can positively impact shareholders by aligning management's interests with the company's long-term success.
• Employees may view the option grant as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, Form 4, director, BeyondSpring Inc., Delaney, beneficial ownership, equity securities